Search research articles

Related Concept Videos

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Home
Circulating, Cell-free Methylated Dna Indicates Cellular Sources Of Allograft Injury After Liver Transplant.

Home
Circulating, Cell-free Methylated Dna Indicates Cellular Sources Of Allograft Injury After Liver Transplant.

Related Experiment Video

Quantification of Circulating Pig-Specific DNA in the Blood of a Xenotransplantation Model

Quantification of Circulating Pig-Specific DNA in the Blood of a Xenotransplantation Model

Published on: September 22, 2020

Circulating, cell-free methylated DNA indicates cellular sources of allograft injury after liver transplant.

Megan E McNamara¹, Sidharth S Jain¹, Kesha Oza^2,3

¹Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.

Biorxiv : the Preprint Server for Biology

|April 15, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Monitoring cell-free DNA (cfDNA) fragments in liver transplant patients can detect early signs of allograft injury. This non-invasive method tracks organ-specific cell damage, enabling timely interventions for better patient outcomes.

More Related Videos

Author Spotlight: Enhancing Transplantation Research Through MicroCT Angiography in Murine Models

Author Spotlight: Enhancing Transplantation Research Through MicroCT Angiography in Murine Models

Published on: September 22, 2023

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Related Experiment Videos

Quantification of Circulating Pig-Specific DNA in the Blood of a Xenotransplantation Model

Quantification of Circulating Pig-Specific DNA in the Blood of a Xenotransplantation Model

Published on: September 22, 2020

Author Spotlight: Enhancing Transplantation Research Through MicroCT Angiography in Murine Models

Author Spotlight: Enhancing Transplantation Research Through MicroCT Angiography in Murine Models

Published on: September 22, 2023

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Area of Science:

Transplantation immunology
Molecular diagnostics
Genomics

Background:

Post-transplant complications significantly impact graft and patient survival.
Current non-invasive methods for detecting allograft injury lack specificity regarding cellular mechanisms.

Purpose of the Study:

To develop a non-invasive method for monitoring cellular damage and detecting early allograft injury after liver transplantation using cell-free DNA (cfDNA).

Main Methods:

Analysis of 130 blood samples from 44 liver transplant patients at various time points.
Sequence-based methylation mapping of cfDNA fragments to identify cell types.
Integration of multi-omic data and DNA methylation patterns to assess cell-specific damage.

Main Results:

Multi-tissue cellular damages post-transplant resolved within the first week in patients without allograft injury.
Sustained elevation of hepatocyte and biliary epithelial cfDNA beyond the first week indicated early-onset allograft injury.
cfDNA composition successfully differentiated among causes of allograft injury.

Conclusions:

cfDNA methylation profiling offers a promising non-invasive approach for early detection and monitoring of liver allograft injury.
This method has the potential to guide timely interventions, improving patient and graft survival.
Distinguishing cfDNA patterns can help identify specific causes of allograft damage.